Unique ID issued by UMIN | UMIN000014581 |
---|---|
Receipt number | R000016963 |
Scientific Title | A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet. |
Date of disclosure of the study information | 2014/07/22 |
Last modified on | 2015/05/13 11:07:36 |
A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
A clinical study for patients with moderate to severe Alzheimer's disease using Memantine hydrochloride OD tablet.
Japan |
Alzheimer's disease
Geriatrics |
Others
NO
To examine improvement of medication adherence, effect of burden reduction and easy to take for caregivers about moderate to severe Alzheimer's patient who are taking Memantine hydrochloride OD tablet.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Evaluation of functionality
Evaluation of safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Switching from Memantine hydrochloride tablet 20mg to Memantine hydrochloride OD tablet 20mg
Intervention period of 4 weeks
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients who are diagnosed as moderate to severe Alzheimer's disease by investigator
2.Patients who have taken Memantine hydrochloride tablet 20mg for 4 weeks before evaluation period
3.Patients who are 20 years or over
4.Patients who are able to understand this study and give informed consent in literature by patient and a caregiver or families
1.Dementia patients except Alzheimer's disease
2.Patients who have severe mental disorder
3.Patients who are pregnant or trying to get pregnant, or during breastfeeding
4.Patients with a history of the hypersensitivity for Memantine hydrochloride tablets
5.The case that a investigator judged to be inappropriate
60
1st name | |
Middle name | |
Last name | Mutsuo Enomoto |
Enomoto naika clinic
Medicine, Geriatrics and Neurology
2-12-9,Tobitakyu Chofu-City,Tokyo,Japan
042-444-0456
info@enomoto-naika-clinic.com
1st name | |
Middle name | |
Last name | Hiroki Kato |
Sogo Rinsho Medefi Company Limited
Business Promotion Department
3-2-7,Nishishinjuku
03-6901-6079
kato.hiroki@sogo-medefi.jp
Enomoto naika clinic
Daiichi Sankyo Company, Limited
Profit organization
NO
榎本内科クリニック
2014 | Year | 07 | Month | 22 | Day |
Published
Completed
2014 | Year | 07 | Month | 04 | Day |
2014 | Year | 08 | Month | 22 | Day |
2014 | Year | 07 | Month | 17 | Day |
2015 | Year | 05 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016963
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |